register

Digital & Innovation

Australian digital company acquired by Japanese multinational

Health Industry Hub | October 11, 2023 |

Digital & Innovation: In a strategic move to fortify its management, technology, and cybersecurity capabilities within the healthcare and public sector in Australia, the Japanese multinational, Fujitsu, has unveiled its plans to acquire Australian digital transformation (DX) company, MF & Associates.

Founded in 2019, Canberra-based MF & Associates marks Fujitsu’s fifth acquisition since 2021 in the ANZ region, as part of a strategic global M&A plan to strengthen business delivery capabilities in key areas. MF & Associates will complement Fujitsu’s recent acquisitions of Microsoft specialist oobe and cybersecurity firm InPhySec to bolster Fujitsu’s security offerings in Australia.

“Fujitsu continues to invest in exceptional DX companies to accelerate our customers’ success,” said Graeme Beardsell, CEO, Fujitsu Asia Pacific.

“We’re experiencing a growing demand for consulting and cybersecurity capabilities, and we are delighted to welcome MF & Associates’ team of highly experienced consultants to Fujitsu to support our customers’ needs.

“At Fujitsu we aim to digitally transform businesses to drive positive, lasting change for our environment, economies and societies, and MF & Associates’ team of experts will further support us in achieving these goals,” he added

Under this new arrangement, MF & Associates is slated to operate as a standalone entity within the Fujitsu portfolio, maintaining its unique identity and retaining all of its team members. The firm will be rebranded as ‘MF&A, a Fujitsu company,’ signaling a seamless integration within the Fujitsu ecosystem while affirming its heritage and autonomy. Mat Franklin, the current Managing Director, will continue to lead MF&A, reporting directly to Stuart Kilduff, CEO of oobe, a Fujitsu Company.

Reimagining healthcare across the entire patient journey: Health Industry HubTM is the only one-stop-hub bringing the diversity of Pharma, MedTech, Diagnostics & Biotech sectors together to inspire meaningful change in healthcare.

The content on Health Industry Hub is copyright protected and can only be accessed under individual user licenses. To subscribe, please click here and visit T&Cs here.


ESG

Landmark National Health and Climate Strategy to roll out 'green procurement guidelines' for medicines and surgical supplies

Landmark National Health and Climate Strategy to roll out ‘green procurement guidelines’ for medicines and surgical supplies

Health Industry Hub | December 5, 2023 |

ESG: At the 28th United Nations Climate Conference (COP28) in Dubai, Ged Kearney MP, Assistant Minister for Health and Aged […]

More


News & Trends - Pharmaceuticals

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

A strategic alignment for HTA Review: Professor Skerritt appointed to Medicines Australia Board

Health Industry Hub | December 5, 2023 |

Pharma News: Professor John Skerritt has been appointed as an Independent Selected Director on the Medicines Australia Board effective 4 […]

More


News & Trends - MedTech & Diagnostics

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Breath of change: Cystic Fibrosis Australia forges pioneering partnership with local medtech

Health Industry Hub | December 5, 2023 |

MedTech & Diagnostics News: In a move aimed at enhancing cystic fibrosis (CF) care and support, Australian-based medical device company, […]

More


News & Trends - Pharmaceuticals

Does the evidence support safety concerns following CAR-T cell therapies?

Does the evidence support safety concerns following CAR-T cell therapies?

Health Industry Hub | December 5, 2023 |

Pharma News: The U.S. Food and Drug Administration (FDA) has launched an investigation into a concerning risk associated with CAR-T […]

More


This content is copyright protected. Please subscribe to gain access.